Literature DB >> 20359656

50 years of allogeneic bone-marrow transplantation.

Ray Powles.   

Abstract

Mesh：

Year:  2010        PMID： 20359656     DOI： 10.1016/S1470-2045(10)70001-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

Review 1.  Nanoparticle-based monitoring of cell therapy.

Authors:  Chenjie Xu; Luye Mu; Isaac Roes; David Miranda-Nieves; Matthias Nahrendorf; James A Ankrum; Weian Zhao; Jeffrey M Karp
Journal:  Nanotechnology       Date:  2011-11-21       Impact factor: 3.874

Review 2.  Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.

Authors:  Hideki Nakasone; Bita Sahaf; David B Miklos
Journal:  Int J Hematol       Date:  2015-03-27       Impact factor: 2.490

3.  Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.

Authors:  Hideki Nakasone; Lu Tian; Bita Sahaf; Takakazu Kawase; Kelsi Schoenrock; Spenser Perloff; Christine E Ryan; Jed Paul; Rakesh Popli; Fang Wu; Joanne M Otani; John Coller; Edus H Warren; David B Miklos
Journal:  Blood       Date:  2015-03-12       Impact factor: 22.113

4.  Adrenaline administration promotes the efficiency of granulocyte colony stimulating factor-mediated hematopoietic stem and progenitor cell mobilization in mice.

Authors:  Chong Chen; Jiang Cao; Xuguang Song; Lingyu Zeng; Zhenyu Li; Yong Li; Kailin Xu
Journal:  Int J Hematol       Date:  2012-12-08       Impact factor: 2.490

5.  Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.

Authors:  C E Bunse; S Tischer; J Lahrberg; M Oelke; C Figueiredo; R Blasczyk; B Eiz-Vesper
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

6.  Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation.

Authors:  H Nakasone; T Fukuda; J Kanda; T Mori; S Yano; T Kobayashi; K Miyamura; T Eto; H Kanamori; K Iwato; N Uchida; S Mori; T Nagamura-Inoue; T Ichinohe; Y Atsuta; T Teshima; M Murata
Journal:  Bone Marrow Transplant       Date:  2014-12-22       Impact factor: 5.483

Review 7.  Commercial nanoparticles for stem cell labeling and tracking.

Authors:  Yaqi Wang; Chenjie Xu; Hooisweng Ow
Journal:  Theranostics       Date:  2013-07-20       Impact factor: 11.556

8.  Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor.

Authors:  Carola E Bunse; Sylvia Borchers; Pavankumar R Varanasi; Sabine Tischer; Constança Figueiredo; Stephan Immenschuh; Ulrich Kalinke; Ulrike Köhl; Lilia Goudeva; Britta Maecker-Kolhoff; Arnold Ganser; Rainer Blasczyk; Eva M Weissinger; Britta Eiz-Vesper
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.